Dr. Judd Moul, professor of surgery and director of the Duke Prostate Center, was quoted in a recent NYTimes article. For the first time, two independent clinical trials have showed that two different drugs give certain patients about two more years before their cancer metastasizes. “‘We’re going from rags to riches,'” says Dr. Moul. Read the full article here.
NYTimes: “Two Prostate Cancer Drugs Delay Spread of the Disease by Two Years”
Search Posts
YOU MAY ALSO LIKE
Related Posts
Employee benefits leaders face unprecedented pressure to deliver meaningful healthcare support, all while navigating rising costs, reducing complexity, and proving...
We’re honored to share that Summus has been named to TIME’s list of the World’s Top HealthTech Companies of 2025....
Cancer is one of the most devastating and costly conditions facing employees and their employers. Each year, cancer accounts for...
Healthcare costs continue to rise, employee expectations are shifting, and benefit leaders are under more pressure than ever to deliver...